Watch Demo

Sweden Lipid Modifying Drug Industry Outlook 2022 - 2026

See how Sweden Lipid Modifying Drug performed compared to key markets such as South Korea, Spain and Italy.

Key Market Indicators

Sales of lipid-modifying medicines in Sweden are predicted to reach $45.2 million by 2026. In 2021, the market value was estimated at $56.65 million—a decrease of around 3.2 percent year-on-year. Since 2005, the Swedish market has registered a yearly decrease of 1.5 percent. In 2021, Sweden was the 15th largest market for lipid-modifying medicines, behind Finland at $56.65 million. Spain, Italy, and Germany held the second, third, and fourth spots in the ranking, respectively.

Marketing Banner

Sweden Lipid Modifying Drug Market Data and Forecasts

How much will Sweden Lipid Modifying Drug Market grow to 2026?

Forecast: Lipid Modifying Medicine Sales in Sweden
Forecast: Lipid Modifying Medicine Sales in Sweden
Forecast: Lipid Modifying Medicine Sales in Sweden
Forecast: Lipid Modifying Medicine Use in Sweden
Forecast: Lipid Modifying Medicine Sales in Sweden
More in Lipid Modifying Drug Industry for 2028